TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• - Global Vascular